CN Stock MarketDetailed Quotes
300391 Changjiang Pharmaceutical Group
- 6.78
- 0.000.00%
Not Open Nov 5 09:30 CST
2.38BMarket Cap-3540P/E (TTM)
0.00High0.00Low0lotVolume0.00Open6.78Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)350.34MShares8.9652wk High169.50P/B2.38BFloat Cap2.2452wk Low8.14Limit Up350.34MShs Float28.95Historical High5.42Limit Down0.00%Amplitude2.24Historical Low--Dividend TTM--Avg Price0lotAsk--Div YieldTTM100Lot Size0lotBid
Changjiang Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -87.24%94.99M | -88.00%68.49M | -69.54%49.4M | -37.85%931.18M | -29.17%744.6M | -37.26%570.89M | -66.22%162.19M | -39.42%1.5B | -29.01%1.05B | -9.11%909.93M |
| Refunds of taxes and levies | -93.91%507.09K | -92.51%503K | -38.68%503K | -54.75%4.02M | 16.33%8.32M | 21.56%6.71M | -75.30%820.31K | -43.86%8.89M | -47.19%7.15M | -42.59%5.52M |
| Cash received relating to other operating activities | -93.66%14.55M | -94.26%10.19M | -88.58%9.91M | -81.55%3.07M | 244.54%229.52M | 327.61%177.53M | 583.02%86.77M | 21.80%16.65M | 13.04%66.62M | -57.95%41.52M |
| Cash inflows from operating activities | -88.80%110.05M | -89.51%79.18M | -76.05%59.81M | -38.42%938.27M | -12.67%982.45M | -21.09%755.13M | -49.66%249.77M | -39.12%1.52B | -27.58%1.13B | -13.75%956.97M |
| Goods services cash paid | -90.25%76.38M | -89.71%61.66M | -70.57%58.78M | -31.47%945.74M | -19.69%783.81M | -27.43%599.04M | -53.86%199.71M | -30.35%1.38B | -15.44%975.93M | -10.86%825.52M |
| Staff behalf paid | -15.43%29.47M | -23.27%18.2M | -14.54%10.14M | -8.20%60.85M | -59.98%34.85M | -67.48%23.72M | -71.10%11.86M | -54.44%66.29M | -18.41%87.08M | 1.76%72.93M |
| All taxes paid | -26.49%6.76M | -22.20%6.11M | 3.02%4.42M | 23.26%16.92M | -67.24%9.2M | -67.99%7.85M | -65.35%4.29M | -60.86%13.73M | -27.98%28.08M | -8.65%24.52M |
| Cash paid relating to other operating activities | -75.40%30.17M | -79.25%23.34M | 101.76%19.29M | -52.04%62.19M | -5.54%122.66M | -8.86%112.48M | -81.53%9.56M | 18.37%129.67M | 90.09%129.85M | 164.46%123.42M |
| Cash outflows from operating activities | -84.98%142.79M | -85.29%109.31M | -58.91%92.63M | -31.71%1.09B | -22.15%950.51M | -28.99%743.09M | -58.10%225.43M | -30.02%1.59B | -10.76%1.22B | -2.32%1.05B |
| Net cash flows from operating activities | -202.52%-32.74M | -350.20%-30.13M | -234.82%-32.82M | -123.12%-147.43M | 133.30%31.94M | 113.46%12.04M | 158.18%24.34M | -128.61%-66.08M | -151.79%-95.92M | -333.71%-89.43M |
| Investing cash flow | ||||||||||
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | ---- | ---- | --78.55K | -94.05%2.38K | -96.30%1.48K | ---- | ---- | -99.30%40K | -99.30%40K |
| Cash received relating to other investing activities | ---- | ---- | ---- | 341.38%171.5M | 1,531.62%28.64M | ---- | ---- | -93.96%38.86M | 251.00%1.76M | ---- |
| Cash inflows from investing activities | ---- | ---- | ---- | 341.58%171.58M | 1,495.40%28.64M | -96.30%1.48K | ---- | -94.83%38.86M | -99.66%1.8M | -99.99%40K |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 12.96%5.7M | 12.35%4.46M | 371.59%2.69M | -86.81%6.79M | -93.42%5.04M | -94.82%3.97M | -99.02%570.55K | -63.82%51.47M | 62.53%76.65M | 419.71%76.67M |
| Cash paid to acquire investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --40.05M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -94.76%40.05M | ---- |
| Cash paid relating to other investing activities | --5.45M | --9.93M | ---- | 101.46%100.33M | ---- | ---- | ---- | 151.53%49.8M | 895.18%86.58M | ---- |
| Cash outflows from investing activities | 121.09%11.15M | 262.56%14.39M | 371.59%2.69M | 5.77%107.12M | -97.52%5.04M | -96.60%3.97M | -99.02%570.55K | -91.60%101.28M | -75.19%203.28M | -79.66%116.72M |
| Net cash flows from investing activities | -147.24%-11.15M | -262.69%-14.39M | -371.59%-2.69M | 203.26%64.45M | 111.71%23.6M | 96.60%-3.97M | 99.02%-570.55K | 86.25%-62.42M | 29.57%-201.48M | -188.94%-116.68M |
| Financing cash flow | ||||||||||
| Cash from borrowing | 26.60%51.5M | --22.5M | --10.25M | -73.06%139.39M | -93.65%40.68M | ---- | ---- | 7.35%517.44M | 76.73%640.79M | 120.08%597.7M |
| Cash received relating to other financing activities | 86.45%79.18M | 21.77%62.81M | 1,133.07%49.44M | 524.54%285.59M | 1.35%42.47M | 57.58%51.58M | -110.94%-4.79M | -87.08%45.73M | -82.48%41.9M | -62.29%32.73M |
| Cash inflows from financing activities | 57.17%130.69M | 65.40%85.31M | 1,347.23%59.69M | -24.54%424.98M | -87.82%83.15M | -91.82%51.58M | -101.06%-4.79M | -32.64%563.17M | 13.46%682.69M | 75.91%630.43M |
| Borrowing repayment | -50.02%60.8M | -65.03%18.49M | -2.76%16.55M | -43.16%255.55M | -71.43%121.64M | -85.49%52.88M | -93.08%17.02M | -20.30%449.56M | -11.39%425.76M | 3.93%364.45M |
| Dividend interest payment | -14.89%21.31M | 11.80%18.45M | 11.51%11.64M | 10.72%62.04M | -34.23%25.04M | -37.92%16.5M | -12.42%10.44M | 50.07%56.03M | 66.71%38.08M | 80.09%26.58M |
| Cash payments relating to other financing activities | --7.32M | 657.58%7.82M | ---- | --29.66M | ---- | -13.18%1.03M | ---- | ---- | ---- | -91.00%1.19M |
| Cash outflows from financing activities | -39.03%89.44M | -36.44%44.76M | 2.67%28.19M | -31.32%347.24M | -68.38%146.68M | -82.05%70.41M | -89.34%27.46M | -20.56%505.59M | -10.62%463.84M | 3.59%392.22M |
| Net cash flows from financing activities | 164.94%41.25M | 315.36%40.56M | 197.70%31.5M | 35.01%77.73M | -129.03%-63.52M | -107.91%-18.83M | -116.61%-32.24M | -71.15%57.58M | 164.41%218.86M | 1,277.90%238.22M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -33.63%20.23K | 229.71%30.84K | 690.51%20.1K | ---- | -21.76%30.48K | -339.92%-23.77K | 98.47%-3.4K | 99.42%-5.61K | 282.19%38.96K | 93.04%-5.4K |
| Net increase in cash and cash equivalents | 67.10%-2.62M | 63.50%-3.94M | 53.00%-3.98M | 92.61%-5.24M | 89.86%-7.96M | -133.59%-10.78M | -109.03%-8.48M | -190.37%-70.93M | -333.34%-78.51M | 243.18%32.1M |
| Add:Begin period cash and cash equivalents | -56.64%6.3M | -45.40%6.3M | -56.64%6.3M | -86.01%11.54M | -82.38%14.53M | -86.01%11.54M | -82.38%14.53M | -22.85%82.47M | -22.85%82.47M | -22.85%82.47M |
| End period cash equivalent | -43.96%3.68M | 211.98%2.37M | -61.73%2.32M | -45.40%6.3M | 65.90%6.57M | -99.34%758.32K | -96.57%6.05M | -86.01%11.54M | -95.54%3.96M | 35.62%114.56M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | -- | -- | -- | -- | China Audit Asia Pacific Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data